quinuclidines has been researched along with Urinary Tract Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Walton, A | 1 |
Brubaker, L; Khandwala, S; Lowder, J; Meikle, SF; Menefee, SA; Nolen, TL; Nygaard, I; Paraiso, MF; Richter, HE; Schaffer, J; Sirls, L; Spino, C; Visco, AG; Wallace, D | 1 |
1 trial(s) available for quinuclidines and Urinary Tract Infections
Article | Year |
---|---|
Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence.
Topics: Aged; Benzilates; Botulinum Toxins, Type A; Cholinergic Antagonists; Double-Blind Method; Female; Humans; Intention to Treat Analysis; Linear Models; Middle Aged; Nortropanes; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence, Urge; Urinary Retention; Urinary Tract Infections; Xerostomia | 2012 |
1 other study(ies) available for quinuclidines and Urinary Tract Infections
Article | Year |
---|---|
Managing overactive bladder symptoms in a palliative care setting.
Topics: Aged, 80 and over; Butylscopolammonium Bromide; Cholinergic Antagonists; Humans; Incontinence Pads; Male; Muscarinic Antagonists; Palliative Care; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Neoplasms; Urinary Bladder, Overactive; Urinary Tract Infections | 2014 |